Logo

Gene Logic Creates Subsidiary in the UK to Promote Business in Europe

Mar 10, 2004

NEW YORK, March 10 (GenomeWeb News) - Gene Logic has established a wholly-owned subsidiary of the same name in the UK, the company said today.

 

Starting this month, the new operation will help facilitate sales, marketing, and customer support in Europe. It has already hired an executive director for business development and will add additional personnel over the coming months.

 

Several European pharmaceutical companies are customers of Gene Logic, which is based in Gaithersburg, Md. "This new Gene Logic initiative enables us to forge a closer working relationship with this portion of our international customer base," said Gene Logic chairman and CEO Mark Gessler in a statement.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.